Literature DB >> 28697130

Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival.

Zeljka Jutric1, Jan Grendar, Helena M Hoen, Sung W Cho, Maria A Cassera, Pippa H Newell, Chet W Hammill, Paul D Hansen, Ronald F Wolf.   

Abstract

OBJECTIVES: Literature addressing the significance of lymph node positivity in the management of nonfunctional pancreatic neuroendocrine tumors (PNETs) is conflicting.
METHODS: The National Cancer Data Base was queried for patients who underwent surgical resection of nonfunctional PNETs between 1998 and 2011. Clinical data and overall survival were analyzed using χ and Cox proportional hazards regression. Multiple imputation was used as a comparative analysis because of the high number of patients missing data on tumor grade.
RESULTS: Two thousand seven hundred thirty-five patients were identified. The overall incidence of lymph node metastasis was 51%. In the subset of patients with grade 1 tumors less than 1 cm, 24% had positive lymph nodes. Overall median survival for patients with negative lymph nodes was 11 years compared with 8 years for lymph node-positive patients (P < 0.001). On multivariate survival analysis, tumor grade, distant metastases, regional lymph node involvement, positive surgical margins, male sex, and older age were predictive of decreased overall survival.
CONCLUSIONS: Lymph node positivity was associated with decreased overall survival. The incidence of lymph node involvement in resected low-grade tumors less than 1 cm is higher than previously reported. Patients selected for resection of PNETs should be offered lymphadenectomy for staging.

Entities:  

Mesh:

Year:  2017        PMID: 28697130     DOI: 10.1097/MPA.0000000000000861

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  11 in total

Review 1.  Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

Authors:  Zu-Yi Ma; Yuan-Feng Gong; Hong-Kai Zhuang; Zi-Xuan Zhou; Shan-Zhou Huang; Yi-Ping Zou; Bo-Wen Huang; Zhong-Hai Sun; Chuan-Zhao Zhang; Yun-Qiang Tang; Bao-Hua Hou
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

2.  Role of Lymph Node Resection and Histopathological Evaluation in Accurate Staging of Nonfunctional Pancreatic Neuroendocrine Tumors: How Many Are Enough?

Authors:  Ding Ding; Ammar A Javed; Chunhui Yuan; Michael J Wright; Zunaira N Javed; Jonathan A Teinor; I Chae Ye; Richard A Burkhart; John L Cameron; Matthew J Weiss; Christopher L Wolfgang; Jin He
Journal:  J Gastrointest Surg       Date:  2020-02-05       Impact factor: 3.452

Review 3.  Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2019-11-27       Impact factor: 4.512

4.  Preoperative prediction of lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors from clinical and MRI features: a multicenter study.

Authors:  Hai-Bin Zhu; Pei Nie; Liu Jiang; Juan Hu; Xiao-Yan Zhang; Xiao-Ting Li; Ming Lu; Ying-Shi Sun
Journal:  Insights Imaging       Date:  2022-10-08

Review 5.  [Surgery of pancreatic neuroendocrine neoplasms: state of the art].

Authors:  A Nießen; S Schimmack; F Billmann; T Hackert
Journal:  Chirurgie (Heidelb)       Date:  2022-05-02

6.  Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.

Authors:  Kota Sahara; Diamantis I Tsilimigras; Rittal Mehta; Amika Moro; Anghela Z Paredes; Alexandra G Lopez-Aguiar; Flavio Rocha; Zaheer Kanji; Sharon Weber; Alexander Fisher; Ryan Fields; Bradley A Krasnick; Kamran Idrees; Paula M Smith; George A Poultsides; Eleftherios Makris; Cliff Cho; Megan Beems; Mary Dillhoff; Shishir K Maithel; Itaru Endo; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2019-12-14       Impact factor: 5.344

7.  Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma.

Authors:  Dong Yang; Ruidong Li; Huili Wang; Junye Wang; Ye Li; Hongbo Wang; Wei Wang; Zifeng Liu
Journal:  Oncol Lett       Date:  2018-06-20       Impact factor: 2.967

8.  C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms.

Authors:  Anna Nießen; Simon Schimmack; Marta Sandini; Dominik Fliegner; Ulf Hinz; Magdalena Lewosinska; Thilo Hackert; Markus W Büchler; Oliver Strobel
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

Review 9.  Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.

Authors:  Andrei Havasi; Daniel Sur; Simona Sorana Cainap; Cristian-Virgil Lungulescu; Laura-Ioana Gavrilas; Calin Cainap; Catalin Vlad; Ovidiu Balacescu
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

10.  Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors.

Authors:  Zheng Zhang; Fei Wang; Zheng Li; Zeng Ye; Qifeng Zhuo; Wenyan Xu; Wensheng Liu; Mengqi Liu; Guixiong Fan; Yi Qin; Yue Zhang; Xuemin Chen; Xianjun Yu; Xiaowu Xu; Shunrong Ji
Journal:  BMC Surg       Date:  2022-05-10       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.